trending Market Intelligence /marketintelligence/en/news-insights/trending/iiuejdl1xzcihdsbu0z8jw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Bellerophon Therapeutics appoints director

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Bellerophon Therapeutics appoints director

Bellerophon Therapeutics Inc. elected Matthew Bennett to its board, filling the vacancy left as a result of Adam Weinstein's resignation.

Bennett is the managing director of New Mountain Capital LLC, a private equity firm, which can nominate a member to the Bellerophon board.

Bennett will serve as a class I director until the end of his term in 2021.

Warren, N.J.-based Bellerophon Therapeutics is developing treatments for heart and lung diseases.